Household Transmission and Immunity to SARS-CoV-2 among Paediatric Clients of a Primary Care Center in a Low-resource Community in Rio de Janeiro

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:19 publications

Grant number: MR/V033530/1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2022
  • Known Financial Commitments (USD)

    $407,561.21
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Dr. Christopher Smith
  • Research Location

    Brazil
  • Lead Research Institution

    London School of Hygiene & Tropical Medicine
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Children (1 year to 12 years)Infants (1 month to 1 year)Newborns (birth to 1 month)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This project aims to characterise household transmission dynamics in Manguinhos, an urban slum (favela), which has one of the lowest Human Development Index (HDI) scores of Rio de Janeiro/Brazil. We will also estimate the immunity of the study population against SARS-CoV-2. This will be a prospective study of household contacts of laboratory-confirmed SARS-CoV-2 infected and non-infected children and their families, following the WHO Household Transmission Investigation Protocol for COVID-19. We will recruit children 0 to 13 years of age who are brought to the local health care centre to receive free vaccinations. The clinic provides primary care to 4,300 children in this age group per month. After obtaining written informed consent from the child's guardian, samples will be collected at the clinic (oral fluid, nasopharyngeal and rectal swabs, and serum). The child's home will then be visited to collect samples from contacts. All samples will be screened for SARS-CoV-2 by PCR following the Charité protocol, and serum for IgG antibodies by ELISA or CLIA and for neutralising antibodies by FRNT. At the household we will collect samples at Days 1 (first visit), 14 and 28, every three months during the first year and twice in the second year. Clinical follow up will be done through telephone calls and video conferences by nurses and paediatricians from Day 0 to Day 28.

Publicationslinked via Europe PMC

Natural, vaccine-induced immunity and the probability of experiencing SARS-CoV-2 infection in a household cohort in Rio de Janeiro.

SARS-CoV-2 Infection and Adverse Maternal and Perinatal Outcomes: Time-to-Event Analysis of a Hospital-Based Cohort Study of Pregnant Women in Rio de Janeiro, Brazil.

SARS-CoV-2 Reinfection Cases in a Household-Based Prospective Cohort in Rio de Janeiro.

Long COVID-19 syndrome associated with Omicron XBB.1.5 infection: a case report.

The Role of Children in Household Transmission of SARS-CoV-2 Across Four Waves of the Pandemic.

Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with BNT162b2, ChAdOx1, or CoronaVac and heterologous boosting.

Accuracy of saliva for SARS-CoV-2 detection in outpatients and their household contacts during the circulation of the Omicron variant of concern.

Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy.

Cohort-profile: Household transmission of SARS-CoV-2 in a low-resource community in Rio de Janeiro, Brazil.